- Home
- CCI vs MRNA Comparison
CCI vs MRNA Comparison
Compare CCI & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCI | MRNA |
|---|---|---|
| Founded | 1994 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1B | 26.7B |
| IPO Year | 1998 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CCI | MRNA |
|---|---|---|
| Price | $78.79 | $62.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 12 |
| Target Price | ★ $104.69 | $34.27 |
| AVG Volume (30 Days) | 4.2M | ★ 9.0M |
| Earning Date | 04-22-2026 | 05-01-2026 |
| Dividend Yield | ★ 4.95% | N/A |
| EPS Growth | ★ 111.25 | 21.77 |
| EPS | ★ 0.34 | N/A |
| Revenue | $4,264,000,000.00 | ★ $19,263,000,000.00 |
| Revenue This Year | N/A | $9.36 |
| Revenue Next Year | $1.72 | $15.43 |
| P/E Ratio | $232.88 | ★ N/A |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $73.75 | $22.28 |
| 52 Week High | $115.76 | $85.60 |
Technical Indicators
Market Signals| Indicator | CCI | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 42.27 | 47.08 |
| Support Level | $77.89 | $45.69 |
| Resistance Level | $92.92 | $85.60 |
| Average True Range (ATR) | 2.28 | 4.83 |
| MACD | 0.48 | -1.83 |
| Stochastic Oscillator | 55.91 | 6.23 |
Price Performance
Historical ComparisonAbout CCI Crown Castle Inc.
Crown Castle owns or manages roughly 40,000 wireless towers in the United States. It leases space on its towers to wireless service providers, which install equipment to support their wireless networks. The company has a very concentrated customer base, with about 90% of its revenue from the Big Three US mobile carriers: Verizon, T-Mobile, and AT&T. Crown Castle has plans to divest its fiber business, which is expected to be finalized in the first half of 2026. After that, it will be a stand-alone tower operator. Crown Castle operates as a real estate investment trust.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.